Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetruffle.com
Twitter@trufflecapital
Phone33-1-47-20-22-20
Employees
Founded2001

Funds

Offices

France
5, rue de la Baume
75008 Paris
FRA

People

Co-Founder and General Partner- Life Sciences
Co-Founder and General Partner- Energy
Co-Founder and President
Co-Founder and General Partner- Information Technology
Venture Partner
Venture Partner
Venture Partner
Venture Partner
Show All People

Service Providers

PR-France

Tags

Truffle Capital

Truffle Capital is a leading independent European private equity firm originally set up for investing in technology spin-offs.

Truffle Capital invests exclusively in Energy, Information Technologies, and Life Sciences companies throughout Europe. The firm is led by a team of four General Partners with decades of successful investment and entrepreneurial experience in Europe and Silicon Valley. They are business-builders who bring a hands-on approach to turning portfolio companies into technology and market leaders.

Recent Milestones

Investments

Company Date Round Size Participants
SP3H 4/2014Venture Round€2.5M1
BoosterMedia 9/2013Series A$5M2
SP3H 5/2012Venture Round€2.2M1
Pharnext 2/2012Venture Round€8M2
Pharnext 9/2011Series B€2.5M1
MyoPowers Medical Technologies 7/2011Series B$16M3
Utel 6/2011Venture Round€2.8M2
Pharnext 6/2010Series A$5.8M2
Immune Targeting Systems 3/2010Series A$13.2M4
PeopleCube 9/2007Venture Round$17M2
Neovacs 7/2007Venture Round€13M2
Cytomics Pharmaceuticals 2/2006Series B€10M3
RF-iT Solutions 1/2006Series A$4.89M2

Videos

Sources

  1. SP3H Raises €2.5M in Funding (finsmes.com) [edit]
  2. BoosterMedia raises $5m as investors see vast growth potential in HTML5 games (gamasutra.com) [edit]
  3. SP3H Raises €2.2M in Funding (finsmes.com) [edit]
  4. Pharnext Raises €8M in Funding (finsmes.com) [edit]
  5. PHARNEXT announces a €2.5 million round of financing (pharnext.com) [edit]
  6. MyoPowers Medical Technologies Closes CHF16M Series B Financing Round (finsmes.com) [edit]
  7. Utel Raises €2.8M in Funding (finsmes.com) [edit]
  8. Pharnext, SAS: Series A $5.8M (onbiovc.com) [edit]
  9. Immune Targeting Systems, Ltd.: Series A $13.2 (onbiovc.com) [edit]
  10. PeopleCube Secures $17M in Funding From Truffle Capital and Big Bang Ventures (peoplecube.com) [edit]
  11. Neovacs, a leading biotech company in the field of therapeutic vaccines in oncology and inflammatory diseases, raises 13 million Euros from a international group of specialist investors, including the Novartis Venture Fund and Truffle Capital (neovacs.fr) [edit]
  12. CYTOMICS SYSTEMS COMPLETES A € 10 MILLION ROUND OF FINANCING (rubicon-net.org) [edit]
  13. EDGAR [edit]
Edit This Page
Last Edited 4/2/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy